Trial
NCT04479436
A Study to Evaluate U3-1402 in Subjects With Advanced or Metastatic Colorectal Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Daiichi Sankyo
Collaborators
—
Condition
Metastatic Colorectal Cancer
Intervention
Patritumab Deruxtecan
Why stopped
Study was terminated early given the Interim Analysis for Part 1 (signal finding) did not meet pre-specified criteria and will not proceed to Part 2. Sponsor will proceed closing the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-18